Bayer explores possible sale of diabetes device unit -Bloomberg
November 24, 2014 at 18:29 PM EST
Nov 24 (Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.
